Amgen Issues Epogen and Procrit Recall - - BioPharm International

ADVERTISEMENT

Amgen Issues Epogen and Procrit Recall



Today, Amgen issued a voluntary recall of 201 lots of Epogen and 155 lots of Procrit (epoitin alfa) because of concern about very thin glass flakes in the vials. The flakes, or lamellae, result from the interaction of the formulation with the glass vials over the shelf life of the product.

The company has announced that according to evaluations conducted by Amgen and Centocor, the risk to patients who have received product included in the recall is low. To date, there have been no complaints or adverse events reported which can be directly attributed to the presence of glass lamellae.  

Epogen and Procrit are both manufactured by Amgen. Epogen is sold by Amgen in the United States.  Centocor Ortho Biotech Products is the authorized distributor of Procrit in the United States.

Lists of the recalled product lots and expiration are available at at www.epogen.com and www.procrit.com.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Merck KGaA Breaks Ground on Facility in China
September 5, 2014
DPT Laboratories Acquires Media Pharmaceuticals' Lakewood Facilities
September 5, 2014
Author Guidelines

Click here